Astrotech Corp ASTC
We take great care to ensure that the data presented and summarized in this overview for ASTROTECH Corp is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding ASTC
View allLatest Institutional Activity in ASTC
Top Purchases
Top Sells
About ASTC
Astrotech Corporation operates as a science and technology development and commercialization company worldwide. It operates through three segments, Astrotech Technologies, Inc. (ATI), 1st Detect Corporation (1st Detect), and AgLAB Inc (AgLAB). The ATI segment owns and licenses the AMS Technology, the platform mass spectrometry technology. The 1st Detect segment manufactures explosives and narcotics trace detectors for use at airports, secured facilities, and borders. This segment provides TRACER 1000, a mass spectrometer based explosives trace detector to replace the explosives trace detectors used at airports, cargo and secured facilities, and borders. The AgLAB segment develops AgLAB-1000, a mass spectrometer for use in the hemp and cannabis market. It also develops BreathTest-1000, a breath analysis tool to screen for volatile organic compound metabolites found in a person's breath. The company was formerly known as SPACEHAB, Inc. and changed its name to Astrotech Corporation in 2009. Astrotech Corporation was incorporated in 1984 is based in Austin, Texas.
Insider Transactions at ASTC
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 29
2024
|
James Frank Becker Director |
BUY
Open market or private purchase
|
Direct |
1,100
+6.39%
|
$9,900
$9.82 P/Share
|
|
May 28
2024
|
James Frank Becker Director |
BUY
Open market or private purchase
|
Direct |
934
+5.85%
|
$8,406
$9.5 P/Share
|
|
May 21
2024
|
Thomas Wiley Wilkinson Director |
BUY
Open market or private purchase
|
Direct |
1,109
+5.05%
|
$9,981
$9.5 P/Share
|
|
Mar 15
2024
|
Daniel T Russler Jr Director |
BUY
Open market or private purchase
|
Direct |
387
+2.53%
|
$3,096
$8.42 P/Share
|
|
Mar 15
2024
|
James Frank Becker Director |
BUY
Open market or private purchase
|
Direct |
649
+4.4%
|
$5,192
$8.25 P/Share
|
|
Mar 13
2024
|
James Frank Becker Director |
BUY
Open market or private purchase
|
Direct |
839
+5.88%
|
$6,712
$8.16 P/Share
|
|
Mar 13
2024
|
Thomas Wiley Wilkinson Director |
BUY
Open market or private purchase
|
Direct |
1,300
+6.17%
|
$10,400
$8.28 P/Share
|
|
Mar 12
2024
|
Daniel T Russler Jr Director |
BUY
Open market or private purchase
|
Direct |
500
+3.33%
|
$4,000
$8.29 P/Share
|
|
Mar 12
2024
|
James Frank Becker Director |
BUY
Open market or private purchase
|
Direct |
958
+7.07%
|
$7,664
$8.14 P/Share
|
|
Dec 29
2023
|
Robert N Mcfarland Director |
BUY
Open market or private purchase
|
Direct |
21
+0.22%
|
$168
$8.34 P/Share
|
|
Dec 27
2023
|
Robert N Mcfarland Director |
BUY
Open market or private purchase
|
Direct |
1,200
+11.02%
|
$9,600
$8.19 P/Share
|
|
Dec 11
2023
|
Daniel T Russler Jr Director |
BUY
Open market or private purchase
|
Direct |
650
+4.43%
|
$4,550
$7.65 P/Share
|
|
Nov 28
2023
|
Jaime Hinojosa CFO |
BUY
Open market or private purchase
|
Direct |
1,000
+12.53%
|
$8,000
$8.19 P/Share
|
|
Nov 28
2023
|
James Frank Becker Director |
BUY
Open market or private purchase
|
Direct |
490
+4.04%
|
$3,920
$8.13 P/Share
|
|
Nov 22
2023
|
James Frank Becker Director |
BUY
Open market or private purchase
|
Direct |
1,100
+8.98%
|
$7,700
$7.47 P/Share
|
|
Nov 20
2023
|
Robert N Mcfarland Director |
BUY
Open market or private purchase
|
Direct |
1,290
+13.18%
|
$9,030
$7.8 P/Share
|
|
Nov 17
2023
|
Robert N Mcfarland Director |
BUY
Open market or private purchase
|
Direct |
54
+0.74%
|
$378
$7.5 P/Share
|
|
Nov 17
2023
|
James Frank Becker Director |
BUY
Open market or private purchase
|
Direct |
1,361
+11.93%
|
$9,527
$7.66 P/Share
|
|
Nov 16
2023
|
Thomas Wiley Wilkinson Director |
BUY
Open market or private purchase
|
Direct |
1,500
+7.52%
|
$10,500
$7.47 P/Share
|
|
Sep 29
2023
|
James Frank Becker Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+36.52%
|
$50,000
$10.1 P/Share
|
Last 12 Months Summary
| Open market or private purchase | 9K shares |
|---|